Anti-AGER (AB2) antibody produced in rabbit
SIGMA/AV41643 - IgG fraction of antiserum
Synonym: Anti-Advanced glycosylation end product-specific receptor; Anti-MGC22357; Anti-RAGE
MDL Number: MFCD06798857
Product Type: Chemical
Immunohistochemistry Anti-AGER (ab2): Cat. No. AV41643: Immunohistochemistry of AGER in Human Kidney tissue with AGER antibody at 4-8 μg/mL.
Immunoblotting Cell Type: Jurkat (Cat. No. AV41643). Lanes 1. Antibody dilution (concentration) 2.5 μg/mL in cell type Jurkat
Immunoblotting AGER Antibody: Cat. No. AV41643: Western Blot analysis of AGER in Human Kidney cell lysates with AGER Antibody at 1.0 μg/mL.
| antibody form | IgG fraction of antiserum |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| concentration | 0.5 mg - 1 mg/mL |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| mol wt | 38 kDa |
| NCBI accession no. | NP_001127   |
| Quality Level | 100 |
| shipped in | wet ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | glycosylation |
| technique(s) | immunohistochemistry: suitable |
| western blot: suitable | |
| UniProt accession no. | Q15109 |
| Application: | Anti-AGER (AB2) polyclonal antibody is used to tag advanced glycation end product receptor protein(s) for detection and quantitation by Western blotting and in cells and tissues by immunohistochemical (IHC) techniques. Anti-AGER (AB2) polyclonal antibody may be used to study the effects/roles of glycation and glyoxidation in cardiovascular disease and diabetes. |
| Biochem/physiol Actions: | AGER mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. It is receptor for amyloid beta peptide.This gene encodes a member of the immunoglobulin superfamily of cell surface molecules. It is a receptor for various molecules, including the amyloidogenic form of serum amyloid A, amyloid-beta protein, members of the S100/calgranulin superfamily and advanced glycation end products. The gene lies within the major histocompatibility complex (MHC) class III region on chromosome 6. Alternative splicing results in two transcript variants encoding different isoforms. |
| Biochem/physiol Actions: | Anti-RAGE (AB2) polyclonal antibody reacts with human advanced glycosylation end product-specific receptor (AGER). |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| General description: | The receptor for advanced glycation end products (RAGE or AGER), a member of the immunoglobulin superfamily, is involved in pathologies such as atherosclerosis, micro- and macrovascular diseases, inflammatory diseases and diabetes. RAGE binds advanced glycation end products (AGE) produced by non-enzymatic glycation or glyoxidation of proteins, lipids and nucleic acids. The previously assigned protein identifier A2BFI7 has been merged into Q15109. Full details can be found on the UniProt database. |
| Immunogen: | Synthetic peptide directed towards the C terminal region of human AGER |
| Other Notes: | Synthetic peptide located within the following region: RIRAGNSSPGPGDPGRPGDSRPAHW |
| Physical form: | Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |